Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer

Journal of Surgical Oncology

Volumn 65, Issue 2, 1997, Pages 127-131

  Mäkelä, Jyrki ^a,b   Kantola, Riitta ^a   Tikkakoski, Tapani ^a,b   Siniluoto, Topi ^a   Leinonen, Sami ^a   Kiviniemi, Heikki ^a   Laitinen, Seppo ^a   Kairaluoma, Matti ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chemotherapy; Colorectal cancer; Hepatic artery infusion therapy; Hepatic metastases

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETERIZATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER TOXICITY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0030790704     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199706)65:2<127::AID-JSO10>3.0.CO;2-2     Document Type: Article

References (26)

1. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: Impact of surgical resection on natural history. Br J Surg 1990;77:1241-1246.
2. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, Bonalumi MG: Mortality and morbidity after hepatic resection of metastases from colorectal cancer. Br J Surg 1995;82:377-381.
3. Ballantyne GH, Quin J: Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71:4252-4266.
4. Balch CM, Levin BJ: Regional and systemic chemotherapy for colorectal metastases to liver. World J Surg 1987;11:521-526.
5. Mäkelä J, Kantola R, Kairaluoma MI: Superselective intra-arterial chemotherapy with mitomycin C for hepatocellular carcinoma. Surg Oncol 1993;2:99-104.
6. Mäkelä J, Kairaluoma MI: Superselective intra-arterial chemotherapy with mitomycin for gallbladder cancer. Br J Surg 1993; 80:912-915.
7. Turnbull RB, Kyle K, Watson FR, Spratt J: Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg 1967;166:420-427.
8. Taylor I: Colorectal liver metastases - to treat or not to treat? Br J Surg 1985;72:511-516.
9. Pettavel J, Morgenthaler F: Protruded arterial chemotherapy of liver tumours: An experience of 197 cases over 12-year period. Ann R Coll Surg Engl 1981;270-266.
10. Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958;8:699-712.
11. Mattson W, Jonsson K, Hellekant C, Hallsten L: Short-term intraarterial mitomycin C in hepatic metastases. Acta Radio Oncol 1980;19:321-325.
12. Wallner KE, Li GC: Effect of drug exposure duration and sequencing on hypertermic potentiation of mitomycin C. Cancer Res 1987;47:493-500.
13. Kerpel-Fronius S, Verweij J, Stuurman M, Kanayr B, Lelieveld P, Pinedo HM: Pharmacokinetics and toxicity of mitomycin C in rodents, given alone, in combination, or after induction of microsomal drug metabolism. Cancer Chemother Pharmacol 1988;22: 104-109.
14. Kennedy KA, Rockwell S, Sartorelli C: Preferential activation of mitomycin C to cytoxic metabolites by hypoxic tumor cells. Cancer Res 1980;40:2356-2360.
15. Milano G, Boublil JL, Bruneton JN: Systemic blood levels after intra-arterial administration of microencapsulated mitomycin C in cancer patients. Eur J Drug Metab Pharmacol 1985;10:197-201.
16. Lise M, Da Pian PP, Nitti D, Pilati PI, Prevaldi C: Colorectal metastases to liver: Present status of management. Dis Colon Rectum 1990;33:688-694.
17. Balch CM, Urist MM, Soong S-J, McGregor M: FURD regional chemotherapy for colorectal metastases using a totally implantable pump. Ann Surg 1983;198:567-573.
18. Johnson LP, Rivkin SE: The implantable pump in metastatic colorectal cancer. Am J Surg 1985;595-598.
19. Goldberg JA, Kerr DJ, Wilmott N, McKillop JH, McArdle CS: Regional chemotherapy for colorectal cancer liver metastases: A phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg 1990;77:1238-1340.
20. Goldberg JA, Kerr DJ, Blackie R, Whately TL, Pettit L, Kato T, McArdle CS: Mitomycin C-loaded microcapsules in the treatment of colorectal liver metastases. Cancer 1991;67:952-955.
21. Stathopoulos GP, Stergiou GS, Golematis B, Thalassinos N, Fillipakis M: Effect of adriamycin, 5-fluorouracil and mitomycin-c combination chemotherapy in advanced colorectal cancer. Oncology 1995;52:306-309.
22. Kemeny N, Cohen A, Seiter K, Contil JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Dudd A: Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993;11:330-335.
23. Marinelli A, Dijkstra FR, van Dierendonck JH, Kuppen PJK, Cornlissse CJ, van de Velde CHJ: Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer. Br J Cancer 1991;64:74-78.
24. Kemeny N, Niedzwiecki D, Shurgot B, Oderman P: Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessement of liver involvement. Cancer 1989;63:742-747.
25. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F: One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991;78:797-801.
26. Krakoff IH: Cessation of treatment in advanced cancer. Cancer 1991;67:1817-1819.